直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Warner-Lambert Company LLC v. Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Warner-Lambert Company LLC v. Sandoz GmbH*

Warner-Lambert Company LLC

Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH

Represented Pfizer group Warner-Lambert in enforcing its second medical use patent for blockbuster drug Lyrica® (pregabalin) as a neuropathic pain treatment against numerous generic companies in the UK and across Europe. Heralded as the IP case of the decade in the UK, it was heard in the Supreme Court in 2018 (having previously been before the Court of Appeal twice) on the most difficult issues in English patent law namely plausibility and infringement of second medical use patents.

Warner-Lambert Company LLC v. Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH, [2015] EWHC 485 (Pat), Claim number: HC-2014-001795, Patents Court

Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH v. Warner-Lambert Company LLC, [2015] EWCA Civ 556, Appeal numbers: A3/2015/0221 and A3/2015/0669, Court of Appeal

Warner-Lambert Company LLC v. Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH, [2015] EWHC 2548 (Pat), Claim numbers: HP-2014-000035, HP-2014-000021, and HC-2014-001795, Patents Court

Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH v. Warner-Lambert Company LLC, [2015] EWHC 2919 (Pat), Claim number: HP-2015-000049, Patents Court

Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH v. Warner-Lambert Company LLC, [2015] EWHC 2924 (Pat), Claim number: HP-2015-000049, Patents Court

Warner-Lambert Company LLC v. Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH, [2015] EWHC 3153 (Pat), Claim number: HP-2015-000049, Patents Court

Warner-Lambert Company LLC v. Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH, [2015] EWHC 3370 (Pat), Claim numbers: HP-2014-000035, HP-2014-000021, and HC-2014-001795, Patents Court

Warner-Lambert Company LLC v. Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH, [2016] EWCA Civ 1006, Appeal numbers: A3/2015/3415, A3/2015/3602, A3/2015/3615, and A3/2016/0017, Court of Appeal

Warner-Lambert Company LLC v. Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH, [2016] EWHC 3317 (Pat), Claim number: HP-2015-000049, Patents Court

Warner-Lambert Company LLC v. Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH, [2018] UKSC 56, Appeal numbers: UKSC 2016/0197, 2017/0069, and 2017/0078, Supreme Court of the United Kingdom

Related Professionals

Jin Ooi
Partner
London
+44 20 7864 2821
Email

Related Practices

Global IP Enforcement, Litigation, and Trials

Patent Litigation and Trials

Related Industries

Life Sciences

Pharmaceutical

Biologics

*Matter handled prior to joining Finnegan.

Related Experiences

Accord Healthcare Limited & Ors v. The Regents of the University of California & Astellas Pharma Europe Ltd.*

The Regents of the University of California & Astellas Pharma Europe Ltd.

Dr Reddy’s Laboratories (UK) Limited & Ors v. Warner-Lambert Company LLC & Anor*

Warner-Lambert Company LLC & Anor

Heraeus Medical GmbH & Anor v. Biomet UK Healthcare Limited & Ors*

Biomet UK Healthcare Limited & Ors

Dr Reddy’s Laboratories (UK) Limited v. Boehringer Ingelheim International GmbH*

Boehringer Ingelheim International GmbH

Microsoft Mobile Oy (Ltd.) v. Sony Europe Ltd & Ors*

Adaptive Spectrum and Signal Alignment Inc v. British Telecommunications PLC*

Iiyama Benelux BV & Ors v. Schott AG & Ors*

Represented a leading multi-category consumer goods company in a series of UK proceedings and coordinated proceedings in Europe and beyond, on patents concerning potentially reduced-risk products including tobacco heating, vaping/e-cigarettes, and modern oral products*

Dorco Company, Ltd. v. The Gillette Company, LLC

Dorco Company, Ltd.

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP